In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on PolyPid (PYPD – Research Report), with a price target ...
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Incyte (INCY – Research Report), Enanta Pharmaceuticals ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback